It’s easier than ever for doctors to prescribe a key medicine for opioid addiction since the U.S. government lifted an obstacle last year. But despite the looser restrictions and the ongoing overdose crisis, a new study finds little change in the number of people taking the medication.
Researchers analyzed prescriptions filled by U.S. pharmacies for the treatment drug buprenorphine. The number of prescribers rose last year after doctors no longer needed to get a special waiver to prescribe the drug, while the number of patients filling prescriptions barely budged.
It may take more than one year to see a bigger increase in patients, said study co-author Dr. Kao-Ping Chua of the University of Michigan Medical School.
“There are so many other barriers to prescribing that we have to address,” said Chua.
The findings were published Wednesday in the New England Journal of Medicine.
Dylan Cease says last year with White Sox 'wasn't enjoyable in really any way'
DeForest Buckner and the Colts have agreed on a $46 million, 2
FIBA 3x3 Asia Cup 2024 men's quarterfinal match: China vs. Australia
Merlier wins Giro Stage 3 after Pogacar fires up finale and stays in the lead
Robert Downey Jr. poses with glamorous wife Susan as they join A
161 ancient tombs unearthed in east China
U.S. Justice Department sues Apple for alleged monopoly in smartphone markets
Justin Steele returns from hamstring injury as Cubs take on Padres
What does science say about the ingredients in functional beverages?